Pricing Log in Create free account

Agenus Inc. (AGEN) vs Benitec Biopharma Limited (BNTC)

Agenus Inc. and Benitec Biopharma Limited are both Biotechnology companies. Agenus Inc. and Benitec Biopharma Limited are of similar size ($301.7M and $295.1M). Benitec Biopharma Limited has negative trailing earnings, so its P/E is not meaningful; Agenus Inc. trades at 2.3×. Agenus Inc. grew revenue faster over the last twelve months: 30.5% against −1.32%. Agenus Inc. has the higher net margin (69.2% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Agenus Inc. leads on 12 and Benitec Biopharma Limited on 4.

Valuation

Metric AGEN BNTC Biotechnology median
P/E 2.28 n/m 8.50
P/S 1.88 5,034.47 9.71
P/B n/m 2.13 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 6.95 n/m 0.64
EV/Sales 2.14 2,636.87 9.21
Earnings yield 43.81% (12.08%) (33.15%)
Free cash flow yield (39.31%) (4.40%) (25.50%)

Profitability

Metric AGEN BNTC Biotechnology median
Gross margin 99.52% 0.00% 65.16%
Operating margin 27.28% 0.00% 0.00%
Net margin 69.18% 0.00% 0.00%
Free cash flow margin (73.97%) 0.00% 0.00%
Return on equity (33.86%) (33.21%) (56.36%)
Return on assets 51.30% (32.28%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AGEN BNTC Biotechnology median
Revenue growth (TTM) 30.47% (1.32%) 6.02%
EPS growth (last fiscal year) 100.00% 6.67% 30.26%
Revenue growth, 5-year CAGR 5.31% (54.02%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AGEN BNTC Biotechnology median
Debt to equity (0.15) 0.00 0.00
Current ratio 0.34 34.00 4.72
Net debt to EBITDA (4.10) 3.52 0.96

Dividend

Metric AGEN BNTC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AGEN BNTC Biotechnology median
Market cap 301.68m 295.08m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack